J. M. Mora-Luján

发表

Gender differences in hereditary hemorrhagic telangiectasia severity

A. Riera-Mestre, P. Cerdà, A. Iriarte, 2020, Orphanet Journal of Rare Diseases.

Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings

A. Riera-Mestre, P. Cerdà, A. Iriarte, 2019, Journal of clinical medicine.

Catheter-Directed Therapies in Patients with Pulmonary Embolism: Predictive Factors of In-Hospital Mortality and Long-Term Follow-Up

A. Riera-Mestre, P. Cerdà, A. Iriarte, 2021, Journal of clinical medicine.

WHO Ordinal Scale and Inflammation Risk Categories in COVID-19. Comparative Study of the Severity Scales

J. Díez-Manglano, F. Formiga, J. Ena, 2022, Journal of General Internal Medicine.

Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

J. Fayós, Manuel Cebrian, M. Bernabeu-Wittel, 2021, Internal and Emergency Medicine.

Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

P. Meybohm, P. Kranke, C. V. D. van der Kallen, 2022, Trials.

Non-retrieved inferior vena cava filters: causes and long-term follow-up.

S. Santos, A. Riera-Mestre, A. Iriarte, 2021, European journal of internal medicine.

Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

M. Monreal, A. Riera-Mestre, P. Cerdà, 2019, Orphanet Journal of Rare Diseases.

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers

M. Méndez Bailón, J. Ena, J. M. Mora-Luján, 2021, Journal of General Internal Medicine.

Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 Registry

F. Formiga, R. Gómez-Huelgas, J. M. Mora-Luján, 2022, Internal and Emergency Medicine.

D-dimer dynamics in hospitalized COVID-19 patients: potential utility for diagnosis of pulmonary embolism.

S. Santos, A. Riera-Mestre, P. Cerdà, 2020, medRxiv.

Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis

J. Rello, C. G. Forero, F. Formiga, 2020, medRxiv.

Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis

S. Santos, A. Riera-Mestre, P. Cerdà, 2020, PloS one.

Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19

J. Ramos-Rincón, R. Gómez-Huelgas, J. M. Mora-Luján, 2020, Journal of clinical medicine.

Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium–aluminum–garnet

L. Puig, A. Riera-Mestre, A. Iriarte, 2021, Dermatologic therapy.

Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review

C. Fondevila, L. Lladó, A. Riera-Mestre, 2022, Journal of clinical medicine.

Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry

M. L. Pérez, J. Salazar-Mendiguchía, A. Riera-Mestre, 2020, Orphanet Journal of Rare Diseases.

Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry

Miguel Ángel Martínez, Yale Tung Chen, Manuel Cebrian, 2023, Internal and Emergency Medicine.

Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

Miguel Ángel Martínez, J. Fayós, Manuel Cebrian, 2021, Drugs.

High-Dose Methylprednisolone Pulses for 3 Days vs. Low-Dose Dexamethasone for 10 Days in Severe, Non-Critical COVID-19: A Retrospective Propensity Score Matched Analysis

F. Formiga, J. M. Mora-Luján, X. Corbella, 2021, Journal of clinical medicine.

Predicting clinical outcome with phenotypic clusters in COVID-19 pneumonia: 2 an analysis of 12,066 hospitalized patients from the Spanish registry SEMI-3 COVID-19.

R. Gómez Huelgas, J. M. Mora-Luján, X. Corbella, 2020, medRxiv.

Long-term use of somatostatin analogs for chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia

A. Riera-Mestre, P. Cerdà, A. Iriarte, 2023, Frontiers in Medicine.